As shown in Figures 3G–J, immunohistochemical staining and immunofluorescence analysis revealed that the expression of Nrf2 was significantly upregulated in the kidneys of CKD patients with hyperlipidemia. Here, NFE2L2 is linked to chronic kidney disease.